| Due Diligence for Asset Managers |
|---|
|
You have viewed 7 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Renovorx Inc | |
|---|---|
| Ticker | RNXT |
| CIK # | 0001574094 |
| CUSIP | 75989R107 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 333 W Santa Clara Street, Suite 900, San Jose, CA 95110 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Renovorx Inc | 2024-04-22 | 11.1 M | Exemption: 506(b) · Remaining: $3,863,443 · Duration: One year or less · Commission: $1,280,937 · Revenue: No Revenues |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001574094] | 10-K | |
| [0001574094] | 10-Q | |
| [0001574094] | 3 | |
| [0001574094] | 4 | |
| [0001574094] | 8-K | |
| [0001574094] | D | |
| [0001574094] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Hirschman Orin | Renovorx Inc | [2025-05-08] | 0.0 |
| AWM Investment Company Inc | Renovorx Inc | [2025-05-07] | 0.0 |
| Bank of the West | Renovorx Inc | [2022-04-14] | 10.79 |
| Najmabadi Kamran | Renovorx Inc | [2022-02-14] | 11.7 |
| AGAH Ramtin | Renovorx Inc | [2022-02-14] | 0.0 |
| Boston Scientific Corp | Renovorx Inc | [2022-02-10] | 6.106 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
VOLL Mark
Common Stock
|
2026-03-25 | Grant | 12,380 | $0.00 | |
|
Bagai Shaun
Common Stock
|
2026-03-20 | Buy | 24,300 | ||
|
VOLL Mark
Common Stock
|
2026-03-20 | Buy | 97,200 | ||
|
Marton Laurence
Common Stock
|
2026-03-20 | Buy | 9,720 | ||
|
Marton Laurence
Warrants · derivative
|
2026-03-20 | Buy | 4,860 | ||
|
Bagai Shaun
Warrants · derivative
|
2026-03-20 | Buy | 12,150 | ||
|
VOLL Mark
Warrants · derivative
|
2026-03-20 | Buy | 48,600 | ||
|
Agah Ramtin
Common Stock
|
2026-01-21 | Buy | 10,000 | $1.00 | 10,000 |
|
Agah Ramtin
Common Stock
|
2025-12-31 | Buy | 9,795 | $0.86 | 8,424 |
|
Agah Ramtin
Common Stock
|
2025-12-30 | Buy | 205 | $0.83 | 170 |
|
Bagai Shaun
Common Stock
|
2025-12-18 | Buy | 5,000 | $0.90 | 4,500 |
|
Bagai Shaun
Common Stock
|
2025-12-17 | Buy | 5,000 | $0.85 | 4,250 |
|
Agah Ramtin
Common Stock
|
2025-12-16 | Buy | 12,000 | $0.85 | 10,200 |
|
Agah Ramtin
Common Stock
|
2025-12-05 | Buy | 10,000 | $0.96 | 9,600 |
|
Agah Ramtin
Common Stock
|
2025-11-24 | Buy | 12,000 | $0.80 | 9,600 |
|
Agah Ramtin
Common Stock
|
2025-11-21 | Buy | 10,000 | $0.80 | 8,000 |
|
MacFarlane K Angela
Stock Options (right to buy) · derivative
|
2025-10-01 | Grant | 47,640 | $0.00 | |
|
Marton Laurence
Stock Options (right to buy) · derivative
|
2025-10-01 | Grant | 47,640 | $0.00 | |
|
Ryan UNA S
Stock Options (right to buy) · derivative
|
2025-10-01 | Grant | 47,640 | $0.00 | |
|
Spiegel Robert J
Stock Options (right to buy) · derivative
|
2025-10-01 | Grant | 47,640 | $0.00 | |
| showing 20 of 106 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 31 | 8,563,907 |
| 2025-12-31 | 33 | 6,575,061 |
| 2025-09-30 | 31 | 7,112,846 |
| 2025-06-30 | 26 | 8,793,596 |
| 2025-03-31 | 28 | 10,076,194 |
| 2024-12-31 | 19 | 1,013,351 |
| 2024-09-30 | 14 | 1,890,069 |
| 2024-06-30 | 18 | 895,219 |
| 2024-03-31 | 11 | 329,664 |
| 2023-12-31 | 13 | 331,179 |
| 2023-09-30 | 15 | 363,630 |
| 2023-06-30 | 10 | 244,336 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Affinity Capital Advisors LLC | [2026-06-30] | SOLE | 0 | 13,279 |
| Midway Capital Research & Management | [2026-06-30] | SOLE | 0 | 6,300 | Prev | Page 1 | Next |